(VONE) Vanguard Russell 1000 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US92206C7305
VONE: ETF Shares, Large-Cap Stocks, Index Fund, US Market, Large Blend
Vanguard Russell1000 Index Fund ETF Shares (NASDAQ:VONE) is an exchange-traded fund that utilizes a passive indexing strategy to mirror the performance of the Russell1000 Index, a benchmark designed to gauge the performance of the US large-cap equity market. By investing substantially all its assets in the constituent stocks of the index, the fund aims to replicate the indexs performance, maintaining a proportionate weighting for each holding.
The funds non-diversified nature implies that it may be more susceptible to significant price swings due to its concentrated holdings. Nonetheless, its tracking of the Russell1000 Index provides broad exposure to the US large-cap market, comprising approximately 1,000 of the largest US stocks. As of the latest data, the funds Assets Under Management (AUM) stand at $5.984 billion, indicating a sizable presence in the market.
Analyzing the technical data, the current price of $272.59 is above both its 20-day Simple Moving Average (SMA) of $267.80 and its 50-day SMA of $255.07, suggesting a bullish trend. The 200-day SMA at $261.82 also supports this upward momentum. The Average True Range (ATR) of 3.35, or 1.23%, indicates moderate volatility. Given the current price is near its 52-week high of $278.58, and considering the upward trend indicated by the SMAs, a potential forecast could be that VONE may continue its upward trajectory, potentially reaching or surpassing its 52-week high in the near term, driven by the overall performance of the US large-cap market.
Combining fundamental and technical analysis, the outlook for VONE appears positive. The funds substantial AUM and its adherence to a well-established index like the Russell1000 Index provide a stable foundation. The technical indicators suggest a continued bullish trend. Therefore, a forecast based on these analyses is that VONE could potentially see its price appreciate, possibly testing resistance levels near its 52-week high. Investors should, however, remain vigilant of market volatility and potential downturns that could affect the funds performance.
Additional Sources for VONE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
VONE ETF Overview
Market Cap in USD | 6,139m |
Category | Large Blend |
TER | 0.08% |
IPO / Inception | 2010-09-20 |
VONE ETF Ratings
Growth Rating | 70.3 |
Fundamental | - |
Dividend Rating | 51.6 |
Rel. Strength | 0.69 |
Analysts | - |
Fair Price Momentum | 266.38 USD |
Fair Price DCF | - |
VONE Dividends
Dividend Yield 12m | 1.24% |
Yield on Cost 5y | 2.50% |
Annual Growth 5y | 4.69% |
Payout Consistency | 93.4% |
Payout Ratio | % |
VONE Growth Ratios
Growth Correlation 3m | 70.2% |
Growth Correlation 12m | 43.9% |
Growth Correlation 5y | 80.8% |
CAGR 5y | 15.57% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 1.61 |
Alpha | 0.48 |
Beta | 1.005 |
Volatility | 11.35% |
Current Volume | 74.3k |
Average Volume 20d | 88.7k |
As of June 15, 2025, the stock is trading at USD 271.20 with a total of 74,325 shares traded.
Over the past week, the price has changed by -0.51%, over one month by +1.53%, over three months by +8.74% and over the past year by +11.98%.
Yes. Based on ValueRay´s Analyses, Vanguard Russell 1000 (NASDAQ:VONE) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.25 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VONE is around 266.38 USD . This means that VONE is currently overvalued and has a potential downside of -1.78%.
Vanguard Russell 1000 has no consensus analysts rating.
According to our own proprietary Forecast Model, VONE Vanguard Russell 1000 will be worth about 304.7 in June 2026. The stock is currently trading at 271.20. This means that the stock has a potential upside of +12.36%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 304.7 | 12.4% |